5-OMe-UDP is a Potent and Selective P2Y6-Receptor Agonist

Tamar Ginsburg-Shmuel, Michael Haas, Marien Schumann, Georg Reiser, Ori Kalid, Noa Stern, Bilha Fischer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


P2Y nucleotide receptors (P2Y-Rs) play important physiological roles. However, most of the P2Y-R subtypes are still lacking potent and selective agonists and antagonists. Based, on data mining analysis of binding interactions in 44 protein-uridine nucleos(t)ides complexes, we designed uracil nucleotides, substituted at the C5/C6 position. All Co-substituted derivatives were inactive at the P2Y2,4,6-Rs, while out of the C5-substituted analogues, only 5-OMe-UD(T)P showed activity. To rationalize the data, the ionization and conformation of these analogues were evaluated. The pKa values of most analogues substituted at the C5/C6 positions were unaltered compared to UTP (pKa 9.42), except for 5-F-UTP nucleotide (pKa 7.85). Co-substituted analogues adopt the syn or high-syn conformations, which are disfavored by the receptors, while 5-OMe-UD(T)P adopt the favored anti conformation. Furthermore, 5-OMe-UDP adopts the S sugar puckering, which is the conformation preferred by the P2Y6-R, but not the P2Y2- or P2Y4-Rs. 5-OMe-UDP fulfills the conformational and H-bonding requirements of P2Y6-R, thus, making a potent P2Y6-R agonist, (EC50 0.08 μM), more than UDP (EC50 0.14μM).

Original languageAmerican English
Pages (from-to)1673-1685
Number of pages13
JournalJournal of Medicinal Chemistry
Issue number4
StatePublished - 25 Feb 2010
Externally publishedYes


Dive into the research topics of '5-OMe-UDP is a Potent and Selective P2Y6-Receptor Agonist'. Together they form a unique fingerprint.

Cite this